NPC1

NPC intracellular cholesterol transporter 1, the group of Solute carrier family 65, NPC-type cholesterol transporters

Basic information

Region (hg38): 18:23506184-23586506

Links

ENSG00000141458NCBI:4864OMIM:607623HGNC:7897Uniprot:O15118AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Strong), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Strong), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR
  • Niemann-Pick disease type C, severe perinatal form (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, severe early infantile neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, late infantile neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, juvenile neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, adult neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Niemann-Pick disease, type C1; Niemann-Pick disease, type DARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Gastrointestinal; Neurologic; Ophthalmologic3865225; 3378364; 9211849; 9245994; 9634529; 9512307; 10361985; 10480349; 11182931; 12555942; 12408188; 15596783; 12955717; 15465421; 15465428; 16098014; 17497724; 17689147; 20301473; 19206179; 20484681; 32033912

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NPC1 gene.

  • Niemann-Pick_disease,_type_C1 (2364 variants)
  • not_provided (431 variants)
  • NPC1-related_disorder (163 variants)
  • Inborn_genetic_diseases (131 variants)
  • not_specified (129 variants)
  • Niemann-Pick_disease,_type_C (104 variants)
  • Sphingomyelin/cholesterol_lipidosis (6 variants)
  • Niemann-Pick_disease,_type_C1,_juvenile_form (4 variants)
  • Headache (2 variants)
  • Russell-Silver_syndrome (2 variants)
  • Dystonic_disorder (2 variants)
  • Cognitive_impairment (2 variants)
  • Niemann-Pick_disease,_type_C1,_adult_form (2 variants)
  • Postural_instability (2 variants)
  • Speech_apraxia (2 variants)
  • Intellectual_disability (2 variants)
  • See_cases (2 variants)
  • Cataplexy (2 variants)
  • Cerebellar_ataxia (2 variants)
  • Abnormality_of_metabolism/homeostasis (2 variants)
  • Niemann-Pick_disease,_type_D (1 variants)
  • Capillary_hemangioma (1 variants)
  • Nasopharyngeal_carcinoma (1 variants)
  • Niemann-Pick_disease,_type_C2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPC1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000271.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
24
clinvar
631
clinvar
3
clinvar
659
missense
47
clinvar
193
clinvar
552
clinvar
31
clinvar
4
clinvar
827
nonsense
45
clinvar
46
clinvar
91
start loss
1
1
2
frameshift
152
clinvar
73
clinvar
5
clinvar
230
splice donor/acceptor (+/-2bp)
19
clinvar
49
clinvar
68
Total 264 363 581 662 7

Highest pathogenic variant AF is 0.0007279364

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NPC1protein_codingprotein_codingENST00000269228 2580715
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000006541.001256550931257480.000370
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.096377190.8850.00004358401
Missense in Polyphen166238.130.69712755
Synonymous-1.073142911.080.00002012503
Loss of Function4.842162.20.3370.00000332715

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005110.000510
Ashkenazi Jewish0.0007940.000794
East Asian0.0002730.000272
Finnish0.0005590.000554
European (Non-Finnish)0.0004050.000404
Middle Eastern0.0002730.000272
South Asian0.0002940.000294
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Intracellular cholesterol transporter which acts in concert with NPC2 and plays an important role in the egress of cholesterol from the endosomal/lysosomal compartment (PubMed:9211849, PubMed:9927649, PubMed:10821832, PubMed:18772377, PubMed:27238017, PubMed:12554680). Unesterified cholesterol that has been released from LDLs in the lumen of the late endosomes/lysosomes is transferred by NPC2 to the cholesterol- binding pocket in the N-terminal domain of NPC1 (PubMed:9211849, PubMed:9927649, PubMed:18772377, PubMed:19563754, PubMed:27238017, PubMed:28784760). Cholesterol binds to NPC1 with the hydroxyl group buried in the binding pocket (PubMed:19563754). Binds oxysterol with higher affinity than cholesterol. May play a role in vesicular trafficking in glia, a process that may be crucial for maintaining the structural and functional integrity of nerve terminals (Probable). {ECO:0000269|PubMed:10821832, ECO:0000269|PubMed:12554680, ECO:0000269|PubMed:18772377, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017, ECO:0000269|PubMed:28784760, ECO:0000269|PubMed:9211849, ECO:0000269|PubMed:9927649, ECO:0000305}.;
Disease
DISEASE: Niemann-Pick disease C1 (NPC1) [MIM:257220]: A lysosomal storage disorder that affects the viscera and the central nervous system. It is due to defective intracellular processing and transport of low-density lipoprotein derived cholesterol. It causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions. Niemann-Pick disease type C1 has a highly variable clinical phenotype. Clinical features include variable hepatosplenomegaly and severe progressive neurological dysfunction such as ataxia, dystonia and dementia. The age of onset can vary from infancy to late adulthood. An allelic variant of Niemann-Pick disease type C1 is found in people with Nova Scotia ancestry. Patients with the Nova Scotian clinical variant are less severely affected. {ECO:0000269|PubMed:10480349, ECO:0000269|PubMed:10521290, ECO:0000269|PubMed:10521297, ECO:0000269|PubMed:11182931, ECO:0000269|PubMed:11333381, ECO:0000269|PubMed:11349231, ECO:0000269|PubMed:11479732, ECO:0000269|PubMed:11545687, ECO:0000269|PubMed:11754101, ECO:0000269|PubMed:12401890, ECO:0000269|PubMed:12408188, ECO:0000269|PubMed:12554680, ECO:0000269|PubMed:12955717, ECO:0000269|PubMed:15774455, ECO:0000269|PubMed:16098014, ECO:0000269|PubMed:16126423, ECO:0000269|PubMed:16802107, ECO:0000269|PubMed:27238017, ECO:0000269|PubMed:9211849, ECO:0000269|PubMed:9634529}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Lysosome - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);Irinotecan Pathway;Ebola Virus Pathway on Host;Ebola Virus Pathway on Host;LDL clearance;Plasma lipoprotein clearance;Transport of small molecules;C21-steroid hormone biosynthesis and metabolism;Plasma lipoprotein assembly, remodeling, and clearance (Consensus)

Recessive Scores

pRec
0.230

Intolerance Scores

loftool
0.0695
rvis_EVS
-0.05
rvis_percentile_EVS
50.02

Haploinsufficiency Scores

pHI
0.197
hipred
Y
hipred_score
0.554
ghis
0.445

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.623

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Npc1
Phenotype
reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); taste/olfaction phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype;

Zebrafish Information Network

Gene name
npc1
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
protein glycosylation;endocytosis;autophagy;lysosomal transport;adult walking behavior;cholesterol metabolic process;bile acid metabolic process;negative regulation of macroautophagy;cholesterol transport;membrane raft organization;intracellular cholesterol transport;cholesterol efflux;low-density lipoprotein particle clearance;response to drug;cholesterol homeostasis;response to cadmium ion;viral entry into host cell;negative regulation of cell death;cellular response to steroid hormone stimulus;cellular response to low-density lipoprotein particle stimulus;establishment of protein localization to membrane
Cellular component
extracellular region;nuclear envelope;lysosome;lysosomal membrane;endoplasmic reticulum;Golgi apparatus;integral component of plasma membrane;membrane;integral component of membrane;late endosome membrane;membrane raft;perinuclear region of cytoplasm;extracellular exosome;integral component of lysosomal membrane
Molecular function
virus receptor activity;transmembrane signaling receptor activity;protein binding;sterol transporter activity;cholesterol binding;signaling receptor activity